scholarly journals Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes

2015 ◽  
pp. 337
Author(s):  
Jennifer Matro ◽  
Yehoda Martei
2021 ◽  
Vol 11 ◽  
Author(s):  
Nam Nhut Phan ◽  
Chih-Yi Hsu ◽  
Chi-Cheng Huang ◽  
Ling-Ming Tseng ◽  
Eric Y. Chuang

PurposeThe present study aimed to assign a risk score for breast cancer recurrence based on pathological whole slide images (WSIs) using a deep learning model.MethodsA total of 233 WSIs from 138 breast cancer patients were assigned either a low-risk or a high-risk score based on a 70-gene signature. These images were processed into patches of 512x512 pixels by the PyHIST tool and underwent color normalization using the Macenko method. Afterward, out of focus and pixelated patches were removed using the Laplacian algorithm. Finally, the remaining patches (n=294,562) were split into 3 parts for model training (50%), validation (7%) and testing (43%). We used 6 pretrained models for transfer learning and evaluated their performance using accuracy, precision, recall, F1 score, confusion matrix, and AUC. Additionally, to demonstrate the robustness of the final model and its generalization capacity, the testing set was used for model evaluation. Finally, the GRAD-CAM algorithm was used for model visualization.ResultsSix models, namely VGG16, ResNet50, ResNet101, Inception_ResNet, EfficientB5, and Xception, achieved high performance in the validation set with an overall accuracy of 0.84, 0.85, 0.83, 0.84, 0.87, and 0.91, respectively. We selected Xception for assessment of the testing set, and this model achieved an overall accuracy of 0.87 with a patch-wise approach and 0.90 and 1.00 with a patient-wise approach for high-risk and low-risk groups, respectively.ConclusionsOur study demonstrated the feasibility and high performance of artificial intelligence models trained without region-of-interest labeling for predicting cancer recurrence based on a 70-gene signature risk score.


Cancer ◽  
2011 ◽  
Vol 118 (10) ◽  
pp. 2594-2602 ◽  
Author(s):  
Elizabeth A. Mittendorf ◽  
Guy T. Clifton ◽  
Jarrod P. Holmes ◽  
Kevin S. Clive ◽  
Ritesh Patil ◽  
...  

2009 ◽  
Vol 69 (8) ◽  
pp. 3425-3432 ◽  
Author(s):  
Christopher L. Neal ◽  
Jun Yao ◽  
Wentao Yang ◽  
Xiaoyan Zhou ◽  
Nina T. Nguyen ◽  
...  

2009 ◽  
Vol 27 (27) ◽  
pp. 4508-4514 ◽  
Author(s):  
Diana S.M. Buist ◽  
Jessica Chubak ◽  
Marianne Prout ◽  
Marianne Ulcickas Yood ◽  
Jaclyn L.F. Bosco ◽  
...  

Purpose Some women with early-stage breast cancer are at higher risk of recurrence and can benefit from chemotherapy. We describe patterns of referral, receipt, and completion of chemotherapy among older women at high risk of recurrence. Patients and Methods A total of 2,124 women age 65 years or older who were diagnosed with early-stage breast cancer between 1990 and 1994 and 1996 to 1999 were included; 1,090 of these were at high risk of recurrence. We reviewed medical records to categorize chemotherapy outcomes as follows: did not discuss or were not referred to a medical oncologist (n = 133); discussed and/or referred to a medical oncologist but received no chemotherapy (n = 742); received an incomplete chemotherapy course (n = 29), or received a completed chemotherapy course (n = 186). Results Overall, 19.7% of high-risk women received any chemotherapy, and 86.5% of these women completed their chemotherapy courses. Just greater than 10% of high-risk women did not have a discussion about chemotherapy as part of breast cancer treatment documented in the medical record; these women also received fewer diagnostic assessments of their initial tumors. Conclusion Individuals who receive chemotherapy for early-stage breast cancer are a select subgroup of patients at high risk of recurrence. This study identifies characteristics of women who were referred for and who received chemotherapy, and this study plays an important role in understanding generalizability of studies that examine chemotherapy treatment effectiveness. Outcomes after breast cancer could continue to be improved with increased receipt of chemotherapy among older women at high risk of breast cancer recurrence.


Sign in / Sign up

Export Citation Format

Share Document